Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-011650

EVP, Chief Medical Officer sold 1,306 shares at $12.12 ($15,833)

From the SEC's structured data for this filing

Trades in this filing

Shah Jatin · EVP, Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-17 Sale : show line 1 in the form −1,306 $12.12 $15,833 129,450 D
Open-market sales · 1,306 sh · avg $12.12 · $15,833
Loading xslF345X03/doc4.xml…